---
title: "Wanbury Ltd (WANBURY) — Share Price, Financials & Analysis"
symbol: "WANBURY"
company: "Wanbury Ltd"
canonical: "https://tapetide.com/stocks/WANBURY"
isin: "INE107F01022"
nse_symbol: "WANBURY"
bse_code: "524212"
sector: "Healthcare"
industry: "Pharmaceuticals & Biotechnology"
market_cap_cr: 827.02
generated_at: "2026-09-13T19:17:28.907Z"
---

# Wanbury Ltd (WANBURY)

Canonical page: https://tapetide.com/stocks/WANBURY

## Company

- **NSE Symbol:** WANBURY
- **BSE Code:** 524212
- **ISIN:** INE107F01022
- **Sector:** Healthcare
- **Industry:** Pharmaceuticals & Biotechnology
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Listed Since:** 2007-01-29
- **CEO:** Mr. Mohan Kumar Rayana
- **Employees:** 1382
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** wanbury.com

## About

Incorporated in 1988, Wanbury Ltd is in the business of pharmaceutical and related activities, including research[1]

## Latest Price

- **Price:** ₹239.35
- **Change:** -2.1 (-0.87%)
- **Open:** ₹240
- **Day High:** ₹240.4
- **Day Low:** ₹234.75
- **Previous Close:** ₹241.45
- **Volume:** 59568
- **As Of:** 2026-09-11T09:59:27+00:00

## Key Fundamentals

Observed at 2026-09-11T04:38:31.692050Z.

- **Market Cap:** ₹827.02 Cr
- **Classification:** Microcap
- **P/E (reported):** 15.1
- **P/E (TTM):** 14.95
- **EPS (TTM):** ₹16.01
- **Book Value:** ₹41.32
- **Price to Book:** 5.86
- **Dividend Yield:** 0%
- **ROE:** 51.51%
- **ROCE:** 27.79%
- **Debt to Equity:** 1.56
- **Revenue (yearly):** ₹603 Cr
- **Net Income:** ₹30.5 Cr
- **EBITDA:** ₹79.8 Cr
- **52-Week High:** ₹358.85
- **52-Week Low:** ₹161.5
- **RSI (14):** 35.75

## Tapetide Score

- **Score:** 42 / 100
- **Score date:** 2026-09-04
- **Archetype:** Out of Favour
- **What it means:** Financially sound, yet the market is not rewarding it. Cases like this usually need a specific reason the pessimism is misplaced, and patience for that reason to play out.
- **Pillar profile:** Quality: Good · Valuation: Fair · Momentum: Falling
- **Percentile:** 19.7 (of 4473 scored stocks)
- **Confidence:** 98%
- **Data coverage:** 95%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 17.79 | 9% |
| growth | 19.07 | 9% |
| momentum | 31.88 | 12% |
| ownership | 67.12 | 24% |
| quality | 63.26 | 22% |
| valuation | 51.07 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Strengths

- Company has delivered good profit growth of 47.8% CAGR over last 5 years
- Company has a good return on equity (ROE) track record: 3 Years ROE 82.2%

### Weaknesses

- Though the company is reporting repeated profits, it is not paying out dividend
- The company has delivered a poor sales growth of 10.6% over past five years.
- Tax rate seems low
- Promoters have pledged 62.2% of their holding.

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | 555.78% | 31.82% | 56.47% |
| ebitda margin growth | -21.27% | 5% | 175.26% | 156.09% |
| net income growth | -33.5% | -45.54% | 107% | 48% |
| revenue growth | -5.93% | 4.22% | 9% | 11% |
| roce | -24.71% | -57.95% | -141.3% | -279.59% |
| roe | -33.42% | -74.28% | 94.48% | 538.29% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 144.46 | 145.5 | 139.41 | 131.11 | 161.19 | 133.45 | 172 | 163.18 | 160.06 | 162.45 | 164.58 | 165.58 |
| Expenses | 127.12 | 124.35 | 121.25 | 120.13 | 141.18 | 119.5 | 142.37 | 138.74 | 134.28 | 135.77 | 134.74 | 149.35 |
| Operating Profit | 17.34 | 21.15 | 18.16 | 10.98 | 20.01 | 13.95 | 29.63 | 24.44 | 25.78 | 26.68 | 29.84 | 16.23 |
| OPM % | 12 | 14.54 | 13.03 | 8.37 | 12.41 | 10.45 | 17.23 | 14.98 | 16.11 | 16.42 | 18.13 | 9.8 |
| Other Income | 0.76 | 0.69 | 0.93 | 0.94 | 1.63 | 0.84 | 1.84 | 0.35 | 0.2 | 0.18 | -3.39 | 0.36 |
| Interest | 7.67 | 8.26 | 7.46 | 7.59 | 10.15 | 10.17 | 9.04 | 7.54 | 7.12 | 7.26 | 8.06 | 7.97 |
| Depreciation | 3.24 | 3.32 | 3.28 | 3.29 | 3.32 | 3.32 | 3.37 | 3.64 | 3.7 | 3.74 | 3.23 | 4.04 |
| Profit before tax | 7.19 | 10.26 | 8.35 | 1.04 | 8.17 | 1.3 | 19.06 | 13.61 | 15.16 | 15.86 | 15.16 | 4.58 |
| Tax % | -2.5 | -0.19 | 3.23 | 0 | 1.84 | 5.38 | -6.3 | 0.88 | -0.13 | 0.69 | -43.14 | 29.26 |
| Net Profit | 7.36 | 10.27 | 8.08 | 1.04 | 8.02 | 1.22 | 20.26 | 13.49 | 15.18 | 15.76 | 21.7 | 3.24 |
| EPS in Rs | 2.25 | 3.14 | 2.47 | 0.32 | 2.45 | 0.37 | 6.18 | 4.1 | 4.35 | 4.52 | 6.21 | 0.93 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 370 | 391 | 367 | 392 | 511 | 500 | 578 | 600 | 650 | 653 |
| Expenses | 438 | 375 | 344 | 374 | 475 | 476 | 506 | 523 | 544 | 554 |
| Operating Profit | -68 | 16 | 23 | 18 | 36 | 23 | 72 | 77 | 107 | 99 |
| OPM % | -18 | 4.1 | 6 | 4.7 | 7 | 4.7 | 12 | 13 | 16 | 15 |
| Other Income | 76 | 9 | 84 | 2 | 77 | 0 | 1 | 3 | -3 | -3 |
| Interest | 31 | 40 | 33 | 23 | 21 | 21 | 29 | 37 | 30 | 30 |
| Depreciation | 10 | 10 | 10 | 10 | 11 | 12 | 13 | 13 | 14 | 15 |
| Profit before tax | -32 | -25 | 65 | -12 | 81 | -10 | 31 | 30 | 60 | 51 |
| Tax % | -1 | -1 | 0 | 2 | 0 | 1 | 1 | -3 | -11 | — |
| Net Profit | -32 | -25 | 64 | -13 | 81 | -10 | 30 | 31 | 66 | 56 |
| EPS in Rs | -13.49 | -10.48 | 25.79 | -5.04 | 24.94 | -3.18 | 9.28 | 9.32 | 18.93 | 16.01 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 23 | 24 | 24 | 25 | 25 | 33 | 33 | 33 | 33 | 35 |
| Reserves | -151 | -183 | -207 | -143 | -156 | -30 | -40 | -5 | 26 | 110 |
| Borrowings | 273 | 224 | 233 | 164 | 166 | 74 | 68 | 116 | 179 | 226 |
| Other Liabilities | 265 | 207 | 235 | 231 | 253 | 275 | 241 | 199 | 176 | 147 |
| Total Liabilities | 411 | 271 | 285 | 277 | 288 | 351 | 302 | 343 | 414 | 518 |
| Fixed Assets | 186 | 178 | 172 | 164 | 167 | 167 | 167 | 167 | 201 | 229 |
| CWIP | 10 | 10 | 9 | 14 | 11 | 2 | 2 | 3 | 5 | 25 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 215 | 83 | 103 | 99 | 109 | 182 | 133 | 173 | 208 | 263 |
| Total Assets | 411 | 271 | 285 | 277 | 288 | 351 | 302 | 343 | 414 | 518 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 43 | 32 | 30 | 44 | 17 | 41 | 20 | 5 | 26 | 32 |
| Cash from Investing Activity | -13 | -1 | -3 | 64 | 8 | 1 | -9 | -17 | -51 | -56 |
| Cash from Financing Activity | -27 | -33 | -27 | -108 | -17 | -29 | -32 | 14 | 26 | 22 |
| Net Cash Flow | 3 | -2 | 0 | 0 | 7 | 13 | -21 | 2 | 1 | -2 |
| Free Cash Flow | 29 | 30 | 25 | 36 | 12 | 42 | 7 | -9 | -22 | -28 |
| CFO/OP | 234 | -49 | 188 | 188 | 97 | 113 | 86 | 7 | 35 | 30 |

### Ratios

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 71 | 29 | 41 | 50 | 32 | 45 | 50 | 56 | 70 | 80 |
| Inventory Days | 63 | 27 | 36 | 25 | 41 | 60 | 26 | 43 | 47 | 67 |
| Days Payable | 259 | 173 | 208 | 252 | 220 | 218 | 178 | 196 | 172 | 142 |
| Cash Conversion Cycle | -124 | -117 | -131 | -176 | -147 | -112 | -101 | -96 | -55 | 6 |
| Working Capital Days | -164 | -251 | -230 | -211 | -227 | -134 | -129 | -37 | 3 | 17 |
| ROCE % | 55 | -1 | 26 | 31 | 23 | 46 | 17 | 58 | 34 | 31 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 39.8% | 39.79% | 39.79% | 39.79% | 39.77% | 39.76% | 39.76% | 39.63% | 43.09% | 43.07% | 43.02% | 43.02% |
| FIIs | 0% | 0% | 0.18% | 0.22% | 1.02% | 0.84% | 1.55% | 1.59% | 0.82% | 0.72% | 0.59% | 0.89% |
| DIIs | 0% | 0.13% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0.06% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 39.53% | 39.1% | 41.81% | 41.42% | 40.66% | 39.61% | 41.78% | 42.06% | 41.19% | 41.28% | 42.17% | 41.91% |
| Others | 20.67% | 20.98% | 18.22% | 18.57% | 18.54% | 19.79% | 16.9% | 16.71% | 14.89% | 14.92% | 14.23% | 14.12% |
| No. of Shareholders | 11634 | 11616 | 13087 | 14400 | 17199 | 17999 | 17889 | 17894 | 17717 | 17261 | 16732 | 17174 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Sell
- **Buy / Neutral / Sell:** 4 / 3 / 12

### Moving Averages — summary: **Strong Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 246.69 | Sell |
| EMA (10) | 246.98 | Sell |
| SMA (20) | 253.98 | Sell |
| EMA (20) | 253.9 | Sell |
| SMA (50) | 280.18 | Sell |
| EMA (50) | 266.54 | Sell |
| SMA (100) | 273.75 | Sell |
| EMA (100) | 268.04 | Sell |
| SMA (200) | 255.77 | Sell |
| EMA (200) | 262.92 | Sell |

### Oscillators — summary: **Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 34.62 | Neutral |
| MACD (12,26,9) | -9.36 | Sell |
| Stochastic (14,3,3) | 11.02 | Buy |
| ADX (14) | 26.9 | Buy |
| Williams %R (14) | -86.95 | Buy |
| ATR (14) | 11.37 | High Volatility |
| ROC (12) | -8.35 | Sell |
| Stoch RSI (14) | 0 | Buy |
| UO (7,14,28) | 39.93 | Neutral |

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-09-02 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9ca32e33-8ac5-4f27-9751-cde4a594a03d.pdf) |
| 2026-08-31 | [Annual Report 2025-26 And Notice Of The 38Th Annual General Meeting Of Wanbury Limited.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0714ff7d-1c30-42b2-a598-54bba603823e.pdf) |
| 2026-08-31 | [Reg. 34 (1) Annual Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8d6242e7-86c5-4b7b-8473-d16d83cfd159.pdf) |
| 2026-08-31 | [Notice Of Book Closure For The Purpose Of 38Th Annual General Meeting (AGM).](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=21a7a95b-a810-4568-9d21-52745775149f.pdf) |
| 2026-08-28 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=85bb1be6-3f89-4589-bef4-d5dbf19e2fb3.pdf) |
| 2026-08-13 | [Announcement under Regulation 30 (LODR)-Press Release / Media Release](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=49a7e4fd-83e2-4ce0-b8a9-0d7494366262.pdf) |
| 2026-08-11 | [Board Meeting Outcome for Outcome Of The Board Meeting Held On August 11 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b292e5e5-5f70-45b0-845b-61fe53d314dc.pdf) |
| 2026-08-11 | [Announcement under Regulation 30 (LODR)-Change in Management](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6ce3005e-328d-451e-ab56-d3c959272cac.pdf) |
| 2026-08-11 | [Announcement under Regulation 30 (LODR)-Press Release / Media Release](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3d68227e-b375-454b-beb9-c2d5e6e24d29.pdf) |
| 2026-08-11 | [Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=96f7282c-b524-43d2-b7c8-c74c4e7747ec.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-08-11 | [Financial Results For The First Quarter Ended 30Th June 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5cc04075-7de3-4ed4-859c-84b46bfcffac.pdf) |
| 2026-05-29 | [Outcome Of The Board Meeting Held On 29.05.2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2d8f657b-4e3a-4fae-b62b-376ae3dc3a79.pdf) |
| 2026-02-05 | [Financial Results For Quarter Ended 31St December 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c02ea3f8-a2b0-480b-b896-7b2ae13fa02f.pdf) |
| 2025-11-13 | [Outcome Of The Board Meeting Held On November 13 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=48ccd51b-46ec-4d2b-914c-345680bb6a91.pdf) |
| 2025-08-04 | [Un-Audited Financial Results](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f8c86c31-f6c9-464c-802d-edcc628a3a37.pdf) |
| 2025-02-13 | [Revised Unaudited Financial Results For The Quarter And Nine Months Ended 31St December 2024.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7407cb99-bf23-41d3-9f68-8763de701645.pdf) |
| 2025-02-12 | [Unaudited Financial Results For The Quarter And Nine Months Ended 31St December 2024.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dc518fac-6a9d-4830-9ee2-73b0809efe48.pdf) |
| 2024-11-13 | [Unaudited Financial Results For The Quarter And Six Months Ended 30Th September, 2024.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=26b2c621-8539-46d4-a2c1-e88eebb6c613.pdf) |
| 2024-08-12 | [Outcome Of The Board Meeting Held On August 12, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1caead46-1b3d-4b18-b072-142b076ab31e.pdf) |
| 2024-05-16 | [Standalone & Consolidated Audited Financial Results (AFR) Of The Company As Per Indian Accounting Standards (Indas) For The Fourth Quarter And Year Ended On 31St March, 2024.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2e96b2c9-c011-4d2e-8934-d56eea7425c6.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 9 Feb - Investor Presentation on Un-audited Financial Results (UFR) for the quarter and nine months ended 31st December, 2025. | [Announcement under Regulation 30 (LODR)-Investor Presentation 9 Feb - Investor Presentation on Un-audited Financial Results (UFR) for the quarter and nine months ended 31st December, 2025.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/ef453e53-0e5a-486c-a99a-0d753a244170.pdf) |
| 8 Apr - Wanbury confirms it does not qualify as a Large Corporate under SEBI debt-securities circulars. | [Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A 8 Apr - Wanbury confirms it does not qualify as a Large Corporate under SEBI debt-securities circulars.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/4d2bdd22-d953-4f6b-b71a-86a0448ca1bf.pdf) |
| 6 Feb - Q3 FY26 revenue Rs162.4Cr, PAT Rs15.8Cr; 9M FY26 revenue Rs485.7Cr, PAT Rs44.4Cr. | [Announcement under Regulation 30 (LODR)-Press Release / Media Release 6 Feb - Q3 FY26 revenue Rs162.4Cr, PAT Rs15.8Cr; 9M FY26 revenue Rs485.7Cr, PAT Rs44.4Cr.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/c3aa1394-2da4-47d3-ac6f-8beb9cc3d9e0.pdf) |
| 6 Apr - Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 6 Apr - Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018](https://www.bseindia.com/xml-data/corpfiling/AttachHis/97b1b0a7-9b68-4b95-9137-4b954ca2ade5.pdf) |
| 5 May - Board meeting on 14 May 2026 to approve Q4 and FY2026 audited financial results. | [Board Meeting Intimation for Notice Of Board Meeting For Approving The Audited Financial Results & Statements Of The Company For The Fourth Quarter And Year Ended 31St March, 2026. 5 May - Board meeting on 14 May 2026 to approve Q4 and FY2026 audited financial results.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/b3057f56-8ff3-46f8-8f56-42b6a3724cc1.pdf) |
| 5 Feb - Outcome of the Board meeting held on 05.02.2026 - Allotment of 47,400 Equity Shares of the Company to eligible employee of the Company who has … | [Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS 5 Feb - Outcome of the Board meeting held on 05.02.2026 - Allotment of 47,400 Equity Shares of the Company to eligible employee of the Company who has …](https://www.bseindia.com/xml-data/corpfiling/AttachHis/35172a65-561d-42e2-89eb-4f325985eafc.pdf) |
| 5 Feb - Board approved Q3/9M FY26 unaudited results; granted 60,000 ESOPs; allotted 47,400 shares on Feb 5, 2026. | [Outcome Of The Board Meeting Held On 05-02-2026 - Grant Of 60000 Stock Options (ESOP''s) To The Employees Of The Company. 5 Feb - Board approved Q3/9M FY26 unaudited results; granted 60,000 ESOPs; allotted 47,400 shares on Feb 5, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/e014b912-2642-48c6-b63b-4fe80987538b.pdf) |
| 28 Apr - Wanbury’s Patalganga site completed MFDS inspection with zero observations on April 7-9, 2026. | [Announcement under Regulation 30 (LODR)-Press Release / Media Release 28 Apr - Wanbury’s Patalganga site completed MFDS inspection with zero observations on April 7-9, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/9f1f90e2-e518-490c-b8d9-3caf1555a9a3.pdf) |
| 28 Apr - Wanbury’s Patalganga site completed MFDS inspection with zero observations on April 7-9, 2026. | [Announcement under Regulation 30 (LODR)-Press Release / Media Release 28 Apr - Wanbury’s Patalganga site completed MFDS inspection with zero observations on April 7-9, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/9f1f90e2-e518-490c-b8d9-3caf1555a9a3.pdf) |
| 24 Mar - Launches Coriminic CPM Drops and NS Nasal Drops for children, targeting ₹861 crore cold liquid market. | [Announcement under Regulation 30 (LODR)-Press Release / Media Release 24 Mar - Launches Coriminic CPM Drops and NS Nasal Drops for children, targeting ₹861 crore cold liquid market.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/79375dfd-8c4c-4253-ab8c-cd7a63933b90.pdf) |

### Investor Presentations

| Date | Document |
| --- | --- |
| 2026-07-01 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=99317c14-77c2-42f2-899e-c73e6d8c06b8.pdf) |
| 2026-02-09 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ef453e53-0e5a-486c-a99a-0d753a244170.pdf) |
| 2025-11-24 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=74cd51c2-344f-4f1c-b7c8-de15cd7651f4.pdf) |
| 2025-11-22 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cd550087-601e-4af5-b0f8-d2f25919a959.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Nov 2025 | [Concall - Nov 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/cd550087-601e-4af5-b0f8-d2f25919a959.pdf) |
| Nov 2025 | [Concall - Nov 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/74cd51c2-344f-4f1c-b7c8-de15cd7651f4.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from nse | [Annual Report 2011 from nse](https://archives.nseindia.com/annual_reports/AR_WANBURY_2010_2011_21092011092526.zip) |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/bfb852b9-1a2e-4cd6-be5e-b2e655e3a6da.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/60dbb82c-b9e2-4c59-b50a-f3c2e6f52803.pdf) |
| from bse | [Annual Report 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/53ff65d2-8ad6-4d5f-9d94-b73c24ee9a86.pdf) |
| from bse | [Annual Report 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/524212/76736524212.pdf) |
| from bse | [Annual Report 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/524212/70977524212.pdf) |
| from bse | [Annual Report 2020 from bse](https://www.bseindia.com/bseplus/AnnualReport/524212/65813524212.pdf) |
| from bse | [Annual Report 2019 from bse](https://www.bseindia.com/bseplus/AnnualReport/524212/5242120319.pdf) |
| from bse | [Annual Report 2018 from bse](https://www.bseindia.com/bseplus/AnnualReport/524212/5242120318.pdf) |
| from bse | [Annual Report 2017 from bse](https://www.bseindia.com/bseplus/AnnualReport/524212/5242120317.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T19:17:28.907Z.